Pages that link to "Q24655168"

The following pages link to Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulation (Q24655168):

Displaying 29 items.

• RNA-Mediated Regulation of HMGA1 Function (Q26820236) (← links)
• Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy (Q26825764) (← links)
• High mobility group a proteins as tumor markers (Q26853205) (← links)
• MicroRNAs as potential signatures of environmental exposure or effect: a systematic review (Q28393390) (← links)
• Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer (Q31119968) (← links)
• The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development (Q33613335) (← links)
• High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer (Q33708134) (← links)
• Generation and characterisation of a canine EGFP-HMGA2 prostate cancer in vitro model (Q33734313) (← links)
• Modeling microRNA-mRNA interactions using PLS regression in human colon cancer (Q33906108) (← links)
• HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28 and let-7 miRNAs in oral squamous cell carcinoma (Q34309093) (← links)
• Overexpression of high mobility group A1 protein in human uveal melanomas: implication for prognosis (Q34918493) (← links)
• Comprehensive analysis of single nucleotide polymorphisms in human microRNAs (Q35040747) (← links)
• Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1. (Q35227751) (← links)
• Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review (Q35371197) (← links)
• The high mobility group A1 molecular switch: turning on cancer - can we turn it off? (Q35504403) (← links)
• Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway (Q36513525) (← links)
• The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer (Q36739216) (← links)
• MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression. (Q37678651) (← links)
• Single nucleotide polymorphisms in microRNA genes are associated with cervical cancer susceptibility in a population from Xinjiang Uygur (Q37687634) (← links)
• Plasma microRNA-320, microRNA-let-7e and microRNA-21 as novel potential biomarkers for the detection of retinoblastoma (Q38807027) (← links)
• Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines. (Q39334102) (← links)
• Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma (Q39539355) (← links)
• Role of miRNA let-7 and its major targets in prostate cancer. (Q41890041) (← links)
• miR-195 Regulates Proliferation and Apoptosis through Inhibiting the mTOR/p70s6k Signaling Pathway by Targeting HMGA2 in Esophageal Carcinoma Cells (Q42114395) (← links)
• Expression of hsa-let-7b-5p, hsa-let-7f-5p, and hsa-miR-222-3p and their putative targets HMGA2 and CDKN1B in typical and atypical carcinoid tumors of the lung. (Q47247387) (← links)
• Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors. (Q54295055) (← links)
• Knockdown of HMGA1 expression by short/small hairpin RNA inhibits growth of ovarian carcinoma cells. (Q54324280) (← links)
• MicroRNA analysis of gastroenteropancreatic neuroendocrine tumors and metastases. (Q55452160) (← links)
• HMGA1 in cancer: Cancer classification by location (Q64279242) (← links)